Palomar Holdings, Inc. Reports Fourth Quarter & Full Year 2023 Results
LA JOLLA, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) — Palomar Holdings, Inc. (NASDAQ:PLMR) (“Palomar” or “Company”) reported net income of […]
Forward Reports Fiscal 2024 First Quarter Results
HAUPPAUGE, N.Y., Feb. 14, 2024 (GLOBE NEWSWIRE) — Forward Industries, Inc. (NASDAQ:FORD), a global design, sourcing and distribution group, today […]
Bridgeline Announces Financial Results for the First Quarter of Fiscal 2024
WOBURN, Mass., Feb. 14, 2024 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of marketing software, today announced […]
Udemy Reports Fourth Quarter and Full Year 2023 Results
Udemy Business full-year 2023 revenue grew 34% year-over-year, driven by the global transformation to a skills-based economy and demand for […]
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results
SEATTLE, Feb. 14, 2024 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that […]
Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28
REDWOOD CITY, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced […]
MYR Group Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Schedule
THORNTON, Colo., Feb. 14, 2024 (GLOBE NEWSWIRE) — MYR Group Inc. (“MYR Group”) (NASDAQ: MYRG), a holding company of leading […]
Udemy Announces Share Repurchase Program
SAN FRANCISCO, Feb. 14, 2024 (GLOBE NEWSWIRE) — Udemy (Nasdaq: UDMY), a leading online skills marketplace and learning platform, today […]
Celularity’s Tri-layer Decellularized, Dehydrated Human Amniotic Membrane Product Investigated as a Carrier of Induced Pluripotent Stem Cell Derived-Limbal Stem Cells in the Treatment of Severe Ocular Surface Disease
-Highlights potential uses of Celularity biomaterials in regenerative medicine applications that combine stem cells and biomaterial scaffolds for use in […]
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
SAN DIEGO, Feb. 14, 2024 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report fourth quarter […]
